GILEAD SCIENCES, INC.

GILD · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $173.9B · 17,000 employees
152
SEC Filings
$135.77
Close 2026-08-11
7
Transcripts
17,000
Employees

Business Summary

Gilead Sciences, Inc. is a biopharmaceutical company that develops and commercializes medicines across therapeutic areas including HIV, viral hepatitis, oncology, and inflammatory diseases. Key products include BIKTARVY and DESCOVY (HIV), VEKLURY (COVID-19), EPCLUSA and HARVONI (hepatitis C), HEPCLUDEX (hepatitis B), TRODELVY and YESCARTA and TECARTUS (oncology), and LIVDELZI (liver disease).

Latest Stock Quote

GILD 2026-08-11 $135.77 O:$132.68 H:$136.85 L:$132.01 Vol:5.5M VWAP:$135.5065
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionGILDdiscussed Cybersecurity
topic_mentionGILDdiscussed Regulation
topic_mentionGILDdiscussed Regulation
topic_mentionGILDdiscussed Healthcare & Bio
topic_mentionGILDdiscussed Blockchain & Crypto
topic_mentionGILDdiscussed Regulation
topic_mentionGILDdiscussed Healthcare & Bio
topic_mentionGILDdiscussed Healthcare & Bio
topic_mentionGILDdiscussed Blockchain & Crypto
topic_mentionGILDdiscussed Regulation
topic_mentionGILDdiscussed Artificial Intelligence
topic_mentionGILDdiscussed Blockchain & Crypto
topic_mentionGILDdiscussed Regulation
topic_mentionGILDdiscussed Healthcare & Bio
topic_mentionGILDdiscussed Artificial Intelligence
topic_mentionGILDdiscussed Cybersecurity
topic_mentionGILDdiscussed Trusted Computing
topic_mentionGILDdiscussed Blockchain & Crypto
topic_mentionGILDdiscussed Semiconductor
topic_mentionGILDdiscussed Networking

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-242025-12-310000882095-26-000006EDGAR67K words
2025-02-282024-12-310000882095-25-000006EDGAR—
2024-02-232023-12-310000882095-24-000007EDGAR—
2023-02-222022-12-310000882095-23-000007EDGAR—
2022-02-232021-12-310000882095-22-000007EDGAR—
2021-02-252020-12-310000882095-21-000008EDGAR—
2020-02-252019-12-310000882095-20-000006EDGAR—
2019-02-262018-12-310000882095-19-000006EDGAR—
2018-02-272017-12-310000882095-18-000008EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-062026-06-300000882095-26-000031EDGAR—
2026-05-072026-03-310000882095-26-000024EDGAR—
2025-11-072025-09-300000882095-25-000047EDGAR40K words
2025-08-072025-06-300000882095-25-000032EDGAR—
2025-05-072025-03-310000882095-25-000012EDGAR—
2024-11-122024-09-300000882095-24-000028EDGAR—
2024-08-082024-06-300000882095-24-000022EDGAR—
2024-05-082024-03-310000882095-24-000013EDGAR—
2023-11-072023-09-300000882095-23-000031EDGAR—
2023-08-042023-06-300000882095-23-000025EDGAR—
2023-05-032023-03-310000882095-23-000017EDGAR—
2022-11-022022-09-300000882095-22-000027EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-040000882095-26-000028EDGAR—
2026-05-200001104659-26-064518EDGAR—
2026-05-070000882095-26-000022EDGAR—
2026-05-040000882095-26-000008EDGAR—
2026-04-280001104659-26-049874EDGAR—
2026-02-230001104659-26-018314EDGAR61K words
2026-02-100000882095-26-000003EDGAR—
2025-11-190001104659-25-113968EDGAR—
2025-10-300000882095-25-000044EDGAR—
2025-10-060000882095-25-000041EDGAR—

152 total filings indexed. 121 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Earnings Transcripts

Call DateQuarterTitle
— GILD Earnings Call Transcript
—Q4 FY2026GILD Q4 FY2026 Earnings Call Transcript
—Q4 FY2026GILD Q4 FY2026 Earnings Call Transcript
—Q4 FY2026GILD Q4 FY2026 Earnings Call Transcript
—Q4 FY2026GILD Q4 FY2026 Earnings Call Transcript
—Q4 FY2026GILD Q4 FY2026 Earnings Call Transcript
—Q4 FY2026GILD Q4 FY2026 Earnings Call Transcript

Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

hiv viral-hepatitis oncology inflammatory-diseases

Company Identity

CIK0000882095
TickerGILD
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.gilead.com
Listed1992-01-22

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 64e7c18f7a39b8b43bd52c87f581a8201ba87fa4fd9845833229d5885fd3755a
parent: a99b720c4c8875fb0e04016d58f8e2c1613c3b256fde42f8cf9fe4195e435a0b
content hash: a50fb476489c3db9da0e7859694938215bdaee6eb5f92773111a77d06b8e21e9
signed: 2026-08-20T19:05:11.823Z
sources: 28 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up GILD using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on GILD, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/GILD (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.